Pathophysiology of Septic Shock

Initial Immune Response Phase

• Sepsis is initiated when pathogen-associated molecular patterns (PAMPs) from microorganisms are recognized by pattern-recognition receptors, triggering inflammatory signaling pathways 1
• This recognition activates inflammatory signaling pathways that converge toward interferon regulatory factor (IRF) signaling and nuclear factor-κB (NF-κB), leading to production of pro-inflammatory cytokines 2
• Early activation of inflammatory genes drives the initial inflammatory response 1
• Damage-associated molecular patterns (DAMPs) released from injured tissues further amplify this inflammatory cascade 3

Endothelial Dysfunction and Coagulopathy

• Sepsis produces profound changes that convert the endothelium from its natural anticoagulant state to a procoagulant state 4
• Disrupted endothelium leads to loss of fluid, recruitment of inflammatory cells, and activation of the coagulation cascade 5
• The coagulation system is activated primarily through upregulation of tissue factor (TF), leading to excessive fibrin deposition and reduced plasmin activity 5
• This creates a vicious cycle where inflammation induces and exacerbates coagulopathies and endothelial injury 4

Hemodynamic Alterations

• Profound circulatory dysfunction characterized by vasodilation is a hallmark of septic shock 6
• Increased vascular permeability leads to fluid leakage into tissues, contributing to hypovolemia 7
• Microcirculatory dysfunction results in tissue hypoperfusion despite potentially normal macrocirculatory parameters 6
• These changes manifest clinically as hypotension requiring vasopressors to maintain mean arterial pressure ≥65 mmHg 7

Cellular and Metabolic Abnormalities

• Altered cellular metabolism leads to lactate accumulation, which is why lactate levels are part of the diagnostic criteria for septic shock 6, 7
• Cellular dysfunction occurs across multiple organ systems, contributing to the development of multiple organ failure 3

Immunosuppressive Phase

• After the initial inflammatory response, sepsis often leads to an immunocompromised state 3
• This phase is characterized by mobilization of immunosuppressive cells, skewing of monocyte differentiation, and production of anti-inflammatory cytokines 3, 8

Clinical Trajectory and Outcomes

• The clinical trajectory of sepsis has evolved to reflect concurrent inflammatory and immunosuppressive responses 8
• Some patients experience a pronounced early inflammatory response leading to multiple organ failure and death 8
• Others survive the early inflammatory response but develop chronic critical illness characterized by persistent inflammation, immunosuppression, and catabolism syndrome (PICS) 3

Common Pitfalls in Understanding Septic Shock Pathophysiology

• Failing to recognize that patients receiving vasopressors may still have perfusion abnormalities despite normal blood pressure 7
• Overlooking the importance of measuring lactate levels, which reflect cellular metabolic dysfunction 6
• Confusing septic shock with other forms of distributive shock, which may lead to inappropriate management 6

Cellular Mechanisms and Clinical Implications of Shock

Acid‑Base Disturbance and Cellular Contractility

• Severe lactic acidosis in shock impairs cellular enzyme activity, reduces myocardial contractility, and diminishes vascular responsiveness to both endogenous and exogenous catecholamines, contributing to hemodynamic instability. 9

Inflammatory Mediator Effects

• Shock, particularly septic shock, triggers massive release of pro‑inflammatory cytokines such as TNF‑α, IL‑1, IL‑6, and IL‑8 from injured cells and activated immune cells, driving systemic inflammation and organ dysfunction. 10
• Oxidative stress during shock leads to lipid peroxidation of cellular membranes, evidenced by elevated isoprostanes and arachidonic‑acid metabolites, which further damages membrane integrity. 10

Immune Cell Dysfunction

• In septic shock, extensive apoptosis of neutrophils and lymphocytes results in a profound loss of immune effector cells, weakening host defense. 11
• Surviving neutrophils exhibit impaired phagocytic capacity and abnormal calcium signaling despite normal appearance, reducing bacterial clearance. 11
• Monocytes display decreased HLA‑DR expression, indicating immune paralysis and compromised antigen presentation. 11

Endothelial Glycocalyx Damage

• Shock induces degradation of the endothelial glycocalyx, increasing vascular permeability and allowing plasma fluid and proteins to leak into the interstitial space, exacerbating tissue edema. 12

Timing of Intervention and Reversibility

• Prolonged shock beyond critical time thresholds leads to irreversible cellular injury; once cells reach this point, restoration of perfusion cannot prevent cell death, underscoring the necessity for early recognition and aggressive treatment to improve survival. 13

Pathophysiology of the Septic Stress Response (Cited Evidence)

Metabolic Derangements

• In septic patients, inflammatory cytokines (e.g., IL‑1β, TNF‑α) and stress hormones (cortisol, catecholamines, glucagon) trigger a profound catabolic state that up‑regulates hormone‑sensitive lipase, leading to massive adipocyte lipolysis and release of free fatty acids (FFAs) and triglycerides that can rise up to four‑fold. 14
• The surge of circulating FFAs is accompanied by down‑regulation of fatty‑acid oxidation enzymes and suppressed ketone production, limiting the ability of tissues to utilize the mobilised lipids. 14
• Accumulation of toxic FFAs damages organ structures and impairs mitochondrial function, further worsening cellular energy deprivation. 14
• Sepsis induces severe hyperglycaemia; excess glucose is preferentially shunted to immune cells to support aerobic glycolysis, which paradoxically amplifies pro‑inflammatory cytokine release, promotes myocardial apoptosis and contributes to multi‑organ dysfunction. 14
• The combined effect of elevated FFAs and disrupted mitochondrial respiration leads to cellular energy failure and contributes to the development of multi‑organ failure. 14
• Systemic inflammation drives catabolism of glycogen, fat and protein, releasing substrates into the circulation that are diverted from maintaining peripheral muscle mass toward immune‑mediated repair processes. 15
• Resultant loss of skeletal muscle tissue imposes both short‑term and long‑term functional deficits for survivors. 15

Immunologic Alterations

• After the initial hyper‑inflammatory phase, sepsis progresses to an immunosuppressive state characterized by extensive apoptosis of lymphocytes, B cells and dendritic cells, leading to a profound depletion of immune effector cells. 16
• Persistent lymphopenia following sepsis onset is an independent predictor of increased mortality. 16
• Surviving neutrophils display impaired phagocytic capacity and abnormal calcium signalling despite a normal appearance, reducing bacterial clearance. 17
• Monocytes exhibit markedly reduced HLA‑DR expression, signifying immune paralysis and compromised antigen presentation. 17
• Bone‑marrow mobilisation of immature polymorphonuclear leukocytes and myeloid‑derived suppressor cells (MDSCs) contributes to the immunosuppressive milieu. 18
• Differentiation of monocytes skews toward an M2 macrophage phenotype that secretes anti‑inflammatory cytokines (IL‑10, TGF‑β). 18
• Professional antigen‑presenting cells down‑regulate HLA‑DR, while T cells up‑regulate inhibitory co‑stimulatory molecules (PD‑1, PD‑L1), expanding regulatory and anergic T‑cell populations. 18

Clinical Trajectory and Outcomes

• Contemporary models describe sepsis as a simultaneous coexistence of hyper‑inflammation and immunosuppression rather than a strictly sequential process. 18
• A subset of patients experiences a dominant early inflammatory response that precipitates rapid multi‑organ failure and death. 18
• Survivors of the early phase may develop chronic critical illness, termed Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS), characterised by ongoing inflammation, immune dysfunction, muscle wasting, re‑activation of latent viral infections and heightened susceptibility to nosocomial pathogens. 18
• Failure to recognise that most patients with prolonged sepsis acquire opportunistic infections underscores the progression to an immunosuppressive disorder. 17